Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126772921 | 12677292 | 1 | I | 20160817 | 20160823 | 20160823 | EXP | PHHY2016VE114833 | NOVARTIS | 44.00 | YR | M | Y | 0.00000 | 20160823 | CN | VE | VE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126772921 | 12677292 | 1 | PS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 5 CM3, Q12H | U | 18927 | SUSPENSION | Q12H | |||||||
126772921 | 12677292 | 2 | C | OXICODAL | OXCARBAZEPINE | 1 | Unknown | 600 MG, Q12H | U | 0 | 600 | MG | Q12H | ||||||
126772921 | 12677292 | 3 | C | EPAMIN | PHENYTOIN SODIUM | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126772921 | 12677292 | 1 | Epilepsy |
126772921 | 12677292 | 2 | Product used for unknown indication |
126772921 | 12677292 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126772921 | 12677292 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126772921 | 12677292 | Pyrexia | |
126772921 | 12677292 | Seizure | |
126772921 | 12677292 | Speech disorder | |
126772921 | 12677292 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |